Pharmacy Benefits Management Services Home

Visual defects and cases of non-arteritic anterior ischaemic optic neuropathy (NAION) have been reported in connection with the intake of PDE5 inhibitors. Physicians should advise patients to stop use of all PDE5 inhibitors, including SPEDRA, and seek medical attention in the event of a sudden loss of vision in one or both eyes. ................
................